Cathie Wood, the founder, CEO, and CIO of Ark Invest, underscored the application of artificial intelligence in the healthcare sector by sharing new research by Mass General Brigham, citing the discovery of cancer survival using facial photograph analysis.

What Happened: Wood reiterated her earlier point on the “profound application” of AI in the healthcare industry, comparing it to the implementation of the same in autonomous vehicles and humanoid robots.

She quoted Dr. Peter H. Diamandis, the founder of Abundance360 and XPRIZE, who highlighted Mass General Brigham research.

According to the researchers at Mass General Brigham, AI was not only able to estimate a person’s biological age, but also improve cancer survival outcomes predictions by just analyzing a facial photograph.

Thus, this marked another small milestone in using AI within the healthcare industry.

Multiomics is a biological analysis approach that integrates data from multiple "omic" fields, like genomics, transcriptomics, proteomics, and metabolomics, to gain an understanding of biological systems.

See Also: Cathie Wood Says AI Innovation In Healthcare Will Be More ‘Profound’ Than Autonomous Taxi Networks, Humanoid Robots

Despot stated that AI-powered molecular diagnostics are changing how diseases are detected early and allowing for precise categorization of individual patient biological profiles.

"AI leverages data from multiomic tools and diagnostics to design more effective drugs, delivering results with higher success rates more quickly and less expensively," he said.

On Monday, the futures of Dow Jones, S&P 500, and Nasdaq 100 indices were trading higher.

Read Next:

• Donald Trump’s EU Tariff Delay Will See ‘Profit Booking In Gold:’ ‘This Is The Beginning Of A Currency War, Which Will Eventually Affect Gold…’
  

Photo courtesy: ChrisStock82 / Shutterstock.com